McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. is quoted in a July 24, 2018 Life Sciences Intellectual Property Review article entitled, “Allergan-tribe ruling raises questions over immunity at PTAB: lawyers.” he US Court of Appeals for the Federal Circuit’s ruling that tribal sovereign immunity doesn’t apply in inter partes review (IPR) proceedings has sparked questions over state protections at the Patent Trial and Appeal Board (PTAB). View the article
